🔎 Trials Near Me

Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › Michigan › Grand Rapids

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di Grand Rapids, MI

15 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi sekitar Grand Rapids (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Menerima pesertaFase 1
  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • BAMF Health, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07189871

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Menerima pesertaFase 1
  • ALX Center 3, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Menerima pesertaFase 2
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05267626

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • Cancer & Hematology Centers of Western Michigan, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Menerima pesertaFase 2
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Trinity Health Grand Rapids Hospital, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Research Site, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07115043

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT05985655

A Study of MGC026 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Feb 2026 · NCT07030257

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Menerima pesertaFase 1/2
  • START Midwest, Grand Rapids
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT06943521

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di kota lain

Studi lain di Grand Rapids

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.